Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Instructions to Comprehend and Use Open Record Extra Offers - 2Benedict Cumberbatch takes on something even Sherlock can’t solve: male grief
- 3Charity 'feels the pinch' of higher energy prices
- 45 Side interests That Work on Psychological wellness
- 5Beneficial Growing Conditions in West Africa Weigh on Cocoa Prices
- Israel Police decry online defamation campaign against female officer in Jerusalem
- PHOTO ESSAY: Summer camp for kids with autoimmune diseases
- Iran executes two men who tried storming military facility during January protest crackdown
- Individual Preparation Administrations to Raise Your Wellness Process
- Satellite space quiz: What's orbiting Earth?
- New York to require social media platforms to display mental health warnings
- Getting ready for a Mechanized World: 10 Positions That computer based intelligence Could Dominate
- Ancient meditation practices find new life in modern religious communities across America
- Cyprus urges hotels to open up, pours funding into tourism
